News

Filter

Topic: Research

January 14, 2021
Acute itching in eczema patients linked to environmental allergens
Newly identified pathway explains why antihistamine drugs often don’t work to control severe itch.
News Release
January 12, 2021
Doctors test popular anti-depressant to see if it fights off COVID-19
Source: CNN
January 8, 2021
Carter named director of OB-GYN clinical research division
Physician-scientist noted for research involving community-based interventions to promote health equity for women, babies.
News Release
January 6, 2021
Improving tests for tropical worm diseases aim of $2.95 million grant
Gates Foundation grant targets global elimination of onchocerciasis, lymphatic filariasis.
News Release
January 4, 2021
For moms, oxygen during childbirth often unnecessary
Research shows no benefits for infants.
News Release
December 28, 2020
Common brain malformation traced to its genetic roots
Discovery could aid early screening, shed light on how Chiari malformation arises.
News Release
December 16, 2020
Protein involved in removing Alzheimer’s buildup linked to circadian rhythm
Brain protein helps explain link between circadian rhythm, Alzheimer’s disease.
News Release
December 9, 2020
Podcast: COVID-19 vaccines around the corner
This episode of 'Show Me the Science' reports on progress toward a vaccine and how to stay safe before vaccines become widely available.
Podcast, Show Me the Science
December 9, 2020
Toxin provides clues to long-term effects of diarrhea caused by E. coli
Bacteria change surface of human intestine to benefit themselves.
News Release
December 7, 2020
Novel form of Alzheimer’s protein found in spinal fluid indicates stage of the disease
Discovery could lead to better diagnostics, speed efforts to find treatment.
News Release
December 3, 2020
Construction progresses on neuroscience research building
Project will be the largest in School of Medicine’s history.
Medical Campus & Community, Video
December 1, 2020
Gene that protects against osteoarthritis identified
In mouse study, loss of molecule contributes to disease while surplus reduces symptoms.
News Release
November 19, 2020
Chaudhuri receives V Scholar Award
Will fund patient-focused cancer research.
National Leaders
November 19, 2020
Clinical trial to evaluate sepsis treatment in children
Trial will enroll patients with life-threatening condition.
News Release
November 18, 2020
Lethal brain infections in mice thwarted by decoy molecule
Discovery of receptor, generation of decoy could help contain outbreaks of Venezuelan equine encephalitis virus.
News Release
November 13, 2020
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm
Findings indicate anti-inflammatory drugs likely to benefit only a fraction of people with severe disease.
News Release
November 12, 2020
Fluvoxamine may prevent serious illness in COVID-19 patients
Antidepressant drug repurposed for patients with coronavirus infection.
News Release
November 10, 2020
Making cancer cells more susceptible to dying
Findings could aid anti-tumor drug development.
News Release
November 4, 2020
Lewis receives national award for volunteerism
Retired psychiatrist participates in, promotes diversity in Alzheimer’s clinical trials.
National Leaders
November 2, 2020
New insight into how brain neurons influence choices
Effort could aid study of addiction, eating disorders, other neuropsychiatric conditions that involve faulty decision-making.
News Release
October 30, 2020
Washington University begins recruiting participants for phase 3 COVID-19 investigational vaccine clinical trial
News Release
October 22, 2020
Alzheimer’s in adults with Down syndrome focus of multicenter NIH grant
As part of grant totaling more than $100 million, Washington University to lead research sections on Alzheimer’s development, genetics.
News Release
October 20, 2020
Morris receives stem cell foundation investigator award
Developmental biologist recognized for research into cell fate.
National Leaders
October 20, 2020
Startup company founded by Washington University scientists acquired by Eli Lilly
Drugmaker purchases Disarm Therapeutics to develop treatments for neurodegenerative diseases.
Medical Campus & Community